Skip to content
healthcare.dev
Get a free key

Ocrevus Zunovo

NDC 50242-554, ocrelizumab and hyaluronidase, injection, solution, from Genentech, Inc..

Product NDC
50242-554
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761371
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-554 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCRELIZUMAB920 mg/23mL
  • HYALURONIDASE (HUMAN RECOMBINANT)23000 U/23mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Antibodies, Monoclonal, Humanized [CS]; CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]; Endoglycosidase [EPC]; Glycoside Hydrolases [CS]

Package NDCNDC-11Package
50242-554-01502420554011 VIAL, SINGLE-USE in 1 CARTON (50242-554-01) / 23 mL in 1 VIAL, SINGLE-USE
50242-554-86502420554861 VIAL, SINGLE-USE in 1 CARTON (50242-554-86) / 23 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b216af61-99d0-42a3-afc2-b5bf86df1ec0

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-554

Use it

Look up 50242-554 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-554 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-554. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.